Deoxyspergualin

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Nippon Kayaku Co., Ltd.

Conditions

Chronic RejectionDiabetes Mellitus, Type 1

Phase 2

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

CompletedNCT00434850

National Institute of Allergy and Infectious Diseases (NIAID)Diabetes Mellitus, Type 1

Start: 2006-10-31End: 2013-11-30Updated: 2016-03-16

Unknown Phase

Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

TerminatedNCT01052259

Nippon Kayaku Co., Ltd.Chronic Rejection

Start: 2009-06-30End: 2012-12-31Updated: 2014-01-08